VCM
MDCO

Voleon Capital Management’s Medicines Co MDCO Stock Holding History

Voleon Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-83,000
Closed -$4.15M – 249
2019
Q3 		$4.15M Buy
+83,000
New +$3.31M 0.32% 65

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Voleon Capital Management's MDCO Position: Q4 2019 in Review

Voleon Capital Management sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 83,000 shares — an estimated $4.15M sold.

Voleon Capital Management first reported a position in MDCO in Q3 2019 and held it in 1 quarter. The position peaked at $4.15M in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Voleon Capital Management reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Voleon Capital Management sold 83,000 Medicines Co shares in Q4 2019, an estimated $4.15M.
  • Voleon Capital Management first reported a position in Medicines Co in Q3 2019 and held it in 1 quarter.
  • Voleon Capital Management's Medicines Co position peaked at $4.15M in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Voleon Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.